|
Fusion Gene Summary | |
Fusion Gene ORF analysis | |
Fusion Genomic Features | |
Fusion Protein Features | |
Fusion Gene Sequence | |
Fusion Gene PPI analysis | |
Related Drugs | |
Related Diseases |
Fusion gene:PTPRF-PSMD3 (FusionGDB2 ID:69949) |
Fusion Gene Summary for PTPRF-PSMD3 |
Fusion gene summary |
Fusion gene information | Fusion gene name: PTPRF-PSMD3 | Fusion gene ID: 69949 | Hgene | Tgene | Gene symbol | PTPRF | PSMD3 | Gene ID | 5792 | 5709 |
Gene name | protein tyrosine phosphatase receptor type F | proteasome 26S subunit, non-ATPase 3 | |
Synonyms | BNAH2|LAR | P58|RPN3|S3|TSTA2 | |
Cytomap | 1p34.2 | 17q21.1 | |
Type of gene | protein-coding | protein-coding | |
Description | receptor-type tyrosine-protein phosphatase FLCA-homologleukocyte antigen-related (LAR) PTP receptorleukocyte antigen-related tyrosine phosphataseleukocyte common antigen relatedprotein tyrosine phosphatase, receptor type, F polypeptidereceptor-linke | 26S proteasome non-ATPase regulatory subunit 326S proteasome regulatory subunit RPN326S proteasome regulatory subunit S3proteasome (prosome, macropain) 26S subunit, non-ATPase, 3proteasome subunit p58tissue specific transplantation antigen 2 | |
Modification date | 20200313 | 20200313 | |
UniProtAcc | . | . | |
Ensembl transtripts involved in fusion gene | ENST00000359947, ENST00000438120, ENST00000372413, ENST00000372414, ENST00000422171, ENST00000496447, | ENST00000264639, ENST00000541736, | |
Fusion gene scores | * DoF score | 22 X 15 X 12=3960 | 16 X 18 X 8=2304 |
# samples | 24 | 21 | |
** MAII score | log2(24/3960*10)=-4.04439411935845 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(21/2304*10)=-3.45567948377619 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
Context | PubMed: PTPRF [Title/Abstract] AND PSMD3 [Title/Abstract] AND fusion [Title/Abstract] | ||
Most frequent breakpoint | PTPRF(44054671)-PSMD3(38146346), # samples:2 | ||
Anticipated loss of major functional domain due to fusion event. |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
Partner | Gene | GO ID | GO term | PubMed ID |
Hgene | PTPRF | GO:0099560 | synaptic membrane adhesion | 26321637 |
Fusion gene breakpoints across PTPRF (5'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Fusion gene breakpoints across PSMD3 (3'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Fusion gene information from two resources (ChiTars 5.0 and ChimerDB 4.0) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
ChimerDB4 | STAD | TCGA-FP-A8CX | PTPRF | chr1 | 44054671 | + | PSMD3 | chr17 | 38146346 | + |
ChimerDB4 | STAD | TCGA-FP-A8CX | PTPRF | chr1 | 44054671 | + | PSMD3 | chr17 | 38146346 | + |
Top |
Fusion Gene ORF analysis for PTPRF-PSMD3 |
Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
In-frame | ENST00000359947 | ENST00000264639 | PTPRF | chr1 | 44054671 | + | PSMD3 | chr17 | 38146346 | + |
In-frame | ENST00000359947 | ENST00000541736 | PTPRF | chr1 | 44054671 | + | PSMD3 | chr17 | 38146346 | + |
In-frame | ENST00000438120 | ENST00000264639 | PTPRF | chr1 | 44054671 | + | PSMD3 | chr17 | 38146346 | + |
In-frame | ENST00000438120 | ENST00000541736 | PTPRF | chr1 | 44054671 | + | PSMD3 | chr17 | 38146346 | + |
In-frame | ENST00000372413 | ENST00000264639 | PTPRF | chr1 | 44054671 | + | PSMD3 | chr17 | 38146346 | + |
In-frame | ENST00000372413 | ENST00000541736 | PTPRF | chr1 | 44054671 | + | PSMD3 | chr17 | 38146346 | + |
In-frame | ENST00000372414 | ENST00000264639 | PTPRF | chr1 | 44054671 | + | PSMD3 | chr17 | 38146346 | + |
In-frame | ENST00000372414 | ENST00000541736 | PTPRF | chr1 | 44054671 | + | PSMD3 | chr17 | 38146346 | + |
intron-3CDS | ENST00000422171 | ENST00000264639 | PTPRF | chr1 | 44054671 | + | PSMD3 | chr17 | 38146346 | + |
intron-3CDS | ENST00000422171 | ENST00000541736 | PTPRF | chr1 | 44054671 | + | PSMD3 | chr17 | 38146346 | + |
intron-3CDS | ENST00000496447 | ENST00000264639 | PTPRF | chr1 | 44054671 | + | PSMD3 | chr17 | 38146346 | + |
intron-3CDS | ENST00000496447 | ENST00000541736 | PTPRF | chr1 | 44054671 | + | PSMD3 | chr17 | 38146346 | + |
ORFfinder result based on the fusion transcript sequence of in-frame fusion genes. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
ENST00000359947 | PTPRF | chr1 | 44054671 | + | ENST00000264639 | PSMD3 | chr17 | 38146346 | + | 2396 | 1289 | 310 | 2016 | 568 |
ENST00000359947 | PTPRF | chr1 | 44054671 | + | ENST00000541736 | PSMD3 | chr17 | 38146346 | + | 2140 | 1289 | 310 | 1896 | 528 |
ENST00000438120 | PTPRF | chr1 | 44054671 | + | ENST00000264639 | PSMD3 | chr17 | 38146346 | + | 2382 | 1275 | 296 | 2002 | 568 |
ENST00000438120 | PTPRF | chr1 | 44054671 | + | ENST00000541736 | PSMD3 | chr17 | 38146346 | + | 2126 | 1275 | 296 | 1882 | 528 |
ENST00000372413 | PTPRF | chr1 | 44054671 | + | ENST00000264639 | PSMD3 | chr17 | 38146346 | + | 2102 | 995 | 16 | 1722 | 568 |
ENST00000372413 | PTPRF | chr1 | 44054671 | + | ENST00000541736 | PSMD3 | chr17 | 38146346 | + | 1846 | 995 | 16 | 1602 | 528 |
ENST00000372414 | PTPRF | chr1 | 44054671 | + | ENST00000264639 | PSMD3 | chr17 | 38146346 | + | 2102 | 995 | 16 | 1722 | 568 |
ENST00000372414 | PTPRF | chr1 | 44054671 | + | ENST00000541736 | PSMD3 | chr17 | 38146346 | + | 1846 | 995 | 16 | 1602 | 528 |
DeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
ENST00000359947 | ENST00000264639 | PTPRF | chr1 | 44054671 | + | PSMD3 | chr17 | 38146346 | + | 0.01836384 | 0.98163617 |
ENST00000359947 | ENST00000541736 | PTPRF | chr1 | 44054671 | + | PSMD3 | chr17 | 38146346 | + | 0.016774751 | 0.9832252 |
ENST00000438120 | ENST00000264639 | PTPRF | chr1 | 44054671 | + | PSMD3 | chr17 | 38146346 | + | 0.018066674 | 0.9819333 |
ENST00000438120 | ENST00000541736 | PTPRF | chr1 | 44054671 | + | PSMD3 | chr17 | 38146346 | + | 0.016231636 | 0.9837684 |
ENST00000372413 | ENST00000264639 | PTPRF | chr1 | 44054671 | + | PSMD3 | chr17 | 38146346 | + | 0.013941145 | 0.9860589 |
ENST00000372413 | ENST00000541736 | PTPRF | chr1 | 44054671 | + | PSMD3 | chr17 | 38146346 | + | 0.014154489 | 0.98584557 |
ENST00000372414 | ENST00000264639 | PTPRF | chr1 | 44054671 | + | PSMD3 | chr17 | 38146346 | + | 0.013941145 | 0.9860589 |
ENST00000372414 | ENST00000541736 | PTPRF | chr1 | 44054671 | + | PSMD3 | chr17 | 38146346 | + | 0.014154489 | 0.98584557 |
Top |
Fusion Genomic Features for PTPRF-PSMD3 |
FusionAI prediction of the potential fusion gene breakpoint based on the pre-mature RNA sequence context (+/- 5kb of individual partner genes, total 20kb length sequence). FusionAI is a fusion gene breakpoint classifier based on convolutional neural network by comparing the fusion positive and negative sequence context of ~ 20K fusion gene data. From here, we can have the relative potentency of the 20K genomic sequence how individual sequnce will be likely used as the gene fusion breakpoints. |
Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | 1-p | p (fusion gene breakpoint) |
PTPRF | chr1 | 44054671 | + | PSMD3 | chr17 | 38146346 | + | 0.000854245 | 0.99914575 |
PTPRF | chr1 | 44054671 | + | PSMD3 | chr17 | 38146346 | + | 0.000854245 | 0.99914575 |
Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions. We integrated a total of 44 different types of human genomic feature loci information across five big categories including virus integration sites, repeats, structural variants, chromatin states, and gene expression regulation. More details are in help page. |
Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions that are ovelapped with the top 1% feature importance score regions. More details are in help page. |
Top |
Fusion Protein Features for PTPRF-PSMD3 |
Go to FGviewer for the breakpoints of chr1:44054671-chr17:38146346 - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. |
Main function of each fusion partner protein. (from UniProt) |
Hgene | Tgene |
. | . |
FUNCTION: Might normally function as a transcriptional repressor. EWS-fusion-proteins (EFPS) may play a role in the tumorigenic process. They may disturb gene expression by mimicking, or interfering with the normal function of CTD-POLII within the transcription initiation complex. They may also contribute to an aberrant activation of the fusion protein target genes. | FUNCTION: Might normally function as a transcriptional repressor. EWS-fusion-proteins (EFPS) may play a role in the tumorigenic process. They may disturb gene expression by mimicking, or interfering with the normal function of CTD-POLII within the transcription initiation complex. They may also contribute to an aberrant activation of the fusion protein target genes. |
Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | PTPRF | chr1:44054671 | chr17:38146346 | ENST00000359947 | + | 8 | 34 | 135_224 | 316.3333333333333 | 1908.0 | Domain | Note=Ig-like C2-type 2 |
Hgene | PTPRF | chr1:44054671 | chr17:38146346 | ENST00000359947 | + | 8 | 34 | 232_314 | 316.3333333333333 | 1908.0 | Domain | Note=Ig-like C2-type 3 |
Hgene | PTPRF | chr1:44054671 | chr17:38146346 | ENST00000359947 | + | 8 | 34 | 33_123 | 316.3333333333333 | 1908.0 | Domain | Note=Ig-like C2-type 1 |
Hgene | PTPRF | chr1:44054671 | chr17:38146346 | ENST00000372413 | + | 6 | 31 | 135_224 | 316.3333333333333 | 1899.0 | Domain | Note=Ig-like C2-type 2 |
Hgene | PTPRF | chr1:44054671 | chr17:38146346 | ENST00000372413 | + | 6 | 31 | 232_314 | 316.3333333333333 | 1899.0 | Domain | Note=Ig-like C2-type 3 |
Hgene | PTPRF | chr1:44054671 | chr17:38146346 | ENST00000372413 | + | 6 | 31 | 33_123 | 316.3333333333333 | 1899.0 | Domain | Note=Ig-like C2-type 1 |
Hgene | PTPRF | chr1:44054671 | chr17:38146346 | ENST00000372414 | + | 6 | 32 | 135_224 | 316.3333333333333 | 1908.0 | Domain | Note=Ig-like C2-type 2 |
Hgene | PTPRF | chr1:44054671 | chr17:38146346 | ENST00000372414 | + | 6 | 32 | 232_314 | 316.3333333333333 | 1908.0 | Domain | Note=Ig-like C2-type 3 |
Hgene | PTPRF | chr1:44054671 | chr17:38146346 | ENST00000372414 | + | 6 | 32 | 33_123 | 316.3333333333333 | 1908.0 | Domain | Note=Ig-like C2-type 1 |
Hgene | PTPRF | chr1:44054671 | chr17:38146346 | ENST00000438120 | + | 8 | 33 | 135_224 | 316.3333333333333 | 1899.0 | Domain | Note=Ig-like C2-type 2 |
Hgene | PTPRF | chr1:44054671 | chr17:38146346 | ENST00000438120 | + | 8 | 33 | 232_314 | 316.3333333333333 | 1899.0 | Domain | Note=Ig-like C2-type 3 |
Hgene | PTPRF | chr1:44054671 | chr17:38146346 | ENST00000438120 | + | 8 | 33 | 33_123 | 316.3333333333333 | 1899.0 | Domain | Note=Ig-like C2-type 1 |
Hgene | PTPRF | chr1:44054671 | chr17:38146346 | ENST00000359947 | + | 8 | 34 | 68_77 | 316.3333333333333 | 1908.0 | Region | Heparin-binding |
Hgene | PTPRF | chr1:44054671 | chr17:38146346 | ENST00000372413 | + | 6 | 31 | 68_77 | 316.3333333333333 | 1899.0 | Region | Heparin-binding |
Hgene | PTPRF | chr1:44054671 | chr17:38146346 | ENST00000372414 | + | 6 | 32 | 68_77 | 316.3333333333333 | 1908.0 | Region | Heparin-binding |
Hgene | PTPRF | chr1:44054671 | chr17:38146346 | ENST00000438120 | + | 8 | 33 | 68_77 | 316.3333333333333 | 1899.0 | Region | Heparin-binding |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | PTPRF | chr1:44054671 | chr17:38146346 | ENST00000359947 | + | 8 | 34 | 1014_1098 | 316.3333333333333 | 1908.0 | Domain | Fibronectin type-III 8 |
Hgene | PTPRF | chr1:44054671 | chr17:38146346 | ENST00000359947 | + | 8 | 34 | 1352_1607 | 316.3333333333333 | 1908.0 | Domain | Tyrosine-protein phosphatase 1 |
Hgene | PTPRF | chr1:44054671 | chr17:38146346 | ENST00000359947 | + | 8 | 34 | 1639_1898 | 316.3333333333333 | 1908.0 | Domain | Tyrosine-protein phosphatase 2 |
Hgene | PTPRF | chr1:44054671 | chr17:38146346 | ENST00000359947 | + | 8 | 34 | 321_411 | 316.3333333333333 | 1908.0 | Domain | Fibronectin type-III 1 |
Hgene | PTPRF | chr1:44054671 | chr17:38146346 | ENST00000359947 | + | 8 | 34 | 416_510 | 316.3333333333333 | 1908.0 | Domain | Fibronectin type-III 2 |
Hgene | PTPRF | chr1:44054671 | chr17:38146346 | ENST00000359947 | + | 8 | 34 | 514_604 | 316.3333333333333 | 1908.0 | Domain | Fibronectin type-III 3 |
Hgene | PTPRF | chr1:44054671 | chr17:38146346 | ENST00000359947 | + | 8 | 34 | 609_706 | 316.3333333333333 | 1908.0 | Domain | Fibronectin type-III 4 |
Hgene | PTPRF | chr1:44054671 | chr17:38146346 | ENST00000359947 | + | 8 | 34 | 711_819 | 316.3333333333333 | 1908.0 | Domain | Fibronectin type-III 5 |
Hgene | PTPRF | chr1:44054671 | chr17:38146346 | ENST00000359947 | + | 8 | 34 | 820_914 | 316.3333333333333 | 1908.0 | Domain | Fibronectin type-III 6 |
Hgene | PTPRF | chr1:44054671 | chr17:38146346 | ENST00000359947 | + | 8 | 34 | 918_1010 | 316.3333333333333 | 1908.0 | Domain | Fibronectin type-III 7 |
Hgene | PTPRF | chr1:44054671 | chr17:38146346 | ENST00000372413 | + | 6 | 31 | 1014_1098 | 316.3333333333333 | 1899.0 | Domain | Fibronectin type-III 8 |
Hgene | PTPRF | chr1:44054671 | chr17:38146346 | ENST00000372413 | + | 6 | 31 | 1352_1607 | 316.3333333333333 | 1899.0 | Domain | Tyrosine-protein phosphatase 1 |
Hgene | PTPRF | chr1:44054671 | chr17:38146346 | ENST00000372413 | + | 6 | 31 | 1639_1898 | 316.3333333333333 | 1899.0 | Domain | Tyrosine-protein phosphatase 2 |
Hgene | PTPRF | chr1:44054671 | chr17:38146346 | ENST00000372413 | + | 6 | 31 | 321_411 | 316.3333333333333 | 1899.0 | Domain | Fibronectin type-III 1 |
Hgene | PTPRF | chr1:44054671 | chr17:38146346 | ENST00000372413 | + | 6 | 31 | 416_510 | 316.3333333333333 | 1899.0 | Domain | Fibronectin type-III 2 |
Hgene | PTPRF | chr1:44054671 | chr17:38146346 | ENST00000372413 | + | 6 | 31 | 514_604 | 316.3333333333333 | 1899.0 | Domain | Fibronectin type-III 3 |
Hgene | PTPRF | chr1:44054671 | chr17:38146346 | ENST00000372413 | + | 6 | 31 | 609_706 | 316.3333333333333 | 1899.0 | Domain | Fibronectin type-III 4 |
Hgene | PTPRF | chr1:44054671 | chr17:38146346 | ENST00000372413 | + | 6 | 31 | 711_819 | 316.3333333333333 | 1899.0 | Domain | Fibronectin type-III 5 |
Hgene | PTPRF | chr1:44054671 | chr17:38146346 | ENST00000372413 | + | 6 | 31 | 820_914 | 316.3333333333333 | 1899.0 | Domain | Fibronectin type-III 6 |
Hgene | PTPRF | chr1:44054671 | chr17:38146346 | ENST00000372413 | + | 6 | 31 | 918_1010 | 316.3333333333333 | 1899.0 | Domain | Fibronectin type-III 7 |
Hgene | PTPRF | chr1:44054671 | chr17:38146346 | ENST00000372414 | + | 6 | 32 | 1014_1098 | 316.3333333333333 | 1908.0 | Domain | Fibronectin type-III 8 |
Hgene | PTPRF | chr1:44054671 | chr17:38146346 | ENST00000372414 | + | 6 | 32 | 1352_1607 | 316.3333333333333 | 1908.0 | Domain | Tyrosine-protein phosphatase 1 |
Hgene | PTPRF | chr1:44054671 | chr17:38146346 | ENST00000372414 | + | 6 | 32 | 1639_1898 | 316.3333333333333 | 1908.0 | Domain | Tyrosine-protein phosphatase 2 |
Hgene | PTPRF | chr1:44054671 | chr17:38146346 | ENST00000372414 | + | 6 | 32 | 321_411 | 316.3333333333333 | 1908.0 | Domain | Fibronectin type-III 1 |
Hgene | PTPRF | chr1:44054671 | chr17:38146346 | ENST00000372414 | + | 6 | 32 | 416_510 | 316.3333333333333 | 1908.0 | Domain | Fibronectin type-III 2 |
Hgene | PTPRF | chr1:44054671 | chr17:38146346 | ENST00000372414 | + | 6 | 32 | 514_604 | 316.3333333333333 | 1908.0 | Domain | Fibronectin type-III 3 |
Hgene | PTPRF | chr1:44054671 | chr17:38146346 | ENST00000372414 | + | 6 | 32 | 609_706 | 316.3333333333333 | 1908.0 | Domain | Fibronectin type-III 4 |
Hgene | PTPRF | chr1:44054671 | chr17:38146346 | ENST00000372414 | + | 6 | 32 | 711_819 | 316.3333333333333 | 1908.0 | Domain | Fibronectin type-III 5 |
Hgene | PTPRF | chr1:44054671 | chr17:38146346 | ENST00000372414 | + | 6 | 32 | 820_914 | 316.3333333333333 | 1908.0 | Domain | Fibronectin type-III 6 |
Hgene | PTPRF | chr1:44054671 | chr17:38146346 | ENST00000372414 | + | 6 | 32 | 918_1010 | 316.3333333333333 | 1908.0 | Domain | Fibronectin type-III 7 |
Hgene | PTPRF | chr1:44054671 | chr17:38146346 | ENST00000438120 | + | 8 | 33 | 1014_1098 | 316.3333333333333 | 1899.0 | Domain | Fibronectin type-III 8 |
Hgene | PTPRF | chr1:44054671 | chr17:38146346 | ENST00000438120 | + | 8 | 33 | 1352_1607 | 316.3333333333333 | 1899.0 | Domain | Tyrosine-protein phosphatase 1 |
Hgene | PTPRF | chr1:44054671 | chr17:38146346 | ENST00000438120 | + | 8 | 33 | 1639_1898 | 316.3333333333333 | 1899.0 | Domain | Tyrosine-protein phosphatase 2 |
Hgene | PTPRF | chr1:44054671 | chr17:38146346 | ENST00000438120 | + | 8 | 33 | 321_411 | 316.3333333333333 | 1899.0 | Domain | Fibronectin type-III 1 |
Hgene | PTPRF | chr1:44054671 | chr17:38146346 | ENST00000438120 | + | 8 | 33 | 416_510 | 316.3333333333333 | 1899.0 | Domain | Fibronectin type-III 2 |
Hgene | PTPRF | chr1:44054671 | chr17:38146346 | ENST00000438120 | + | 8 | 33 | 514_604 | 316.3333333333333 | 1899.0 | Domain | Fibronectin type-III 3 |
Hgene | PTPRF | chr1:44054671 | chr17:38146346 | ENST00000438120 | + | 8 | 33 | 609_706 | 316.3333333333333 | 1899.0 | Domain | Fibronectin type-III 4 |
Hgene | PTPRF | chr1:44054671 | chr17:38146346 | ENST00000438120 | + | 8 | 33 | 711_819 | 316.3333333333333 | 1899.0 | Domain | Fibronectin type-III 5 |
Hgene | PTPRF | chr1:44054671 | chr17:38146346 | ENST00000438120 | + | 8 | 33 | 820_914 | 316.3333333333333 | 1899.0 | Domain | Fibronectin type-III 6 |
Hgene | PTPRF | chr1:44054671 | chr17:38146346 | ENST00000438120 | + | 8 | 33 | 918_1010 | 316.3333333333333 | 1899.0 | Domain | Fibronectin type-III 7 |
Hgene | PTPRF | chr1:44054671 | chr17:38146346 | ENST00000359947 | + | 8 | 34 | 1548_1554 | 316.3333333333333 | 1908.0 | Region | Substrate binding |
Hgene | PTPRF | chr1:44054671 | chr17:38146346 | ENST00000372413 | + | 6 | 31 | 1548_1554 | 316.3333333333333 | 1899.0 | Region | Substrate binding |
Hgene | PTPRF | chr1:44054671 | chr17:38146346 | ENST00000372414 | + | 6 | 32 | 1548_1554 | 316.3333333333333 | 1908.0 | Region | Substrate binding |
Hgene | PTPRF | chr1:44054671 | chr17:38146346 | ENST00000438120 | + | 8 | 33 | 1548_1554 | 316.3333333333333 | 1899.0 | Region | Substrate binding |
Hgene | PTPRF | chr1:44054671 | chr17:38146346 | ENST00000359947 | + | 8 | 34 | 1285_1907 | 316.3333333333333 | 1908.0 | Topological domain | Cytoplasmic |
Hgene | PTPRF | chr1:44054671 | chr17:38146346 | ENST00000359947 | + | 8 | 34 | 30_1263 | 316.3333333333333 | 1908.0 | Topological domain | Extracellular |
Hgene | PTPRF | chr1:44054671 | chr17:38146346 | ENST00000372413 | + | 6 | 31 | 1285_1907 | 316.3333333333333 | 1899.0 | Topological domain | Cytoplasmic |
Hgene | PTPRF | chr1:44054671 | chr17:38146346 | ENST00000372413 | + | 6 | 31 | 30_1263 | 316.3333333333333 | 1899.0 | Topological domain | Extracellular |
Hgene | PTPRF | chr1:44054671 | chr17:38146346 | ENST00000372414 | + | 6 | 32 | 1285_1907 | 316.3333333333333 | 1908.0 | Topological domain | Cytoplasmic |
Hgene | PTPRF | chr1:44054671 | chr17:38146346 | ENST00000372414 | + | 6 | 32 | 30_1263 | 316.3333333333333 | 1908.0 | Topological domain | Extracellular |
Hgene | PTPRF | chr1:44054671 | chr17:38146346 | ENST00000438120 | + | 8 | 33 | 1285_1907 | 316.3333333333333 | 1899.0 | Topological domain | Cytoplasmic |
Hgene | PTPRF | chr1:44054671 | chr17:38146346 | ENST00000438120 | + | 8 | 33 | 30_1263 | 316.3333333333333 | 1899.0 | Topological domain | Extracellular |
Hgene | PTPRF | chr1:44054671 | chr17:38146346 | ENST00000359947 | + | 8 | 34 | 1264_1284 | 316.3333333333333 | 1908.0 | Transmembrane | Helical |
Hgene | PTPRF | chr1:44054671 | chr17:38146346 | ENST00000372413 | + | 6 | 31 | 1264_1284 | 316.3333333333333 | 1899.0 | Transmembrane | Helical |
Hgene | PTPRF | chr1:44054671 | chr17:38146346 | ENST00000372414 | + | 6 | 32 | 1264_1284 | 316.3333333333333 | 1908.0 | Transmembrane | Helical |
Hgene | PTPRF | chr1:44054671 | chr17:38146346 | ENST00000438120 | + | 8 | 33 | 1264_1284 | 316.3333333333333 | 1899.0 | Transmembrane | Helical |
Tgene | PSMD3 | chr1:44054671 | chr17:38146346 | ENST00000264639 | 4 | 12 | 26_32 | 292.3333333333333 | 535.0 | Compositional bias | Note=Poly-Pro | |
Tgene | PSMD3 | chr1:44054671 | chr17:38146346 | ENST00000264639 | 4 | 12 | 286_465 | 292.3333333333333 | 535.0 | Domain | PCI |
Top |
Fusion Gene Sequence for PTPRF-PSMD3 |
For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. To have fusion amino acid sequence, we ran ORFfinder and chose the longest ORF among the all predicted ones. |
>In-frame_ENST00000359947_ENST00000264639_TCGA-FP-A8CX_PTPRF_chr1_44054671_+_PSMD3_chr17_38146346_length(transcript)=2396nt_BP=1289nt CGGGAGCGGCGGGAGCGGTGGCGGCGGCAGAGGCGGCGGCTCCAGCTTCGGCTCCGGCTCGGGCTCGGGCTCCGGCTCCGGCTCCGGCTC CGGCTCCAGCTCGGGTGGCGGTGGCGGGAGCGGGACCAGGTGGAGGCGGCGGCGGCAGAGGAGTGGGAGCAGCGGCCCTAGCGGCTTGCG GGGGGACATGCGGACCGACGGCCCCTGGATAGGCGGAAGGAGTGGAGGCCCTGGTGCCCGGCCCTTGGTGCTGAGTATCCAGCAAGAGTG ACCGGGGTGAAGAAGCAAAGACTCGGTTGATTGTCCTGGGCTGTGGCTGGCTGTGGAGCTAGAGCCCTGGATGGCCCCTGAGCCAGCCCC AGGGAGGACGATGGTGCCCCTTGTGCCTGCACTGGTGATGCTTGGTTTGGTGGCAGGCGCCCATGGTGACAGCAAACCTGTCTTCATTAA AGTCCCTGAGGACCAGACTGGGCTGTCAGGAGGGGTAGCCTCCTTCGTGTGCCAAGCTACAGGAGAACCCAAGCCGCGCATCACATGGAT GAAGAAGGGGAAGAAAGTCAGCTCCCAGCGCTTCGAGGTCATTGAGTTTGATGATGGGGCAGGGTCAGTGCTTCGGATCCAGCCATTGCG GGTGCAGCGAGATGAAGCCATCTATGAGTGTACAGCTACTAACAGCCTGGGTGAGATCAACACTAGTGCCAAGCTCTCAGTGCTCGAAGA GGAACAGCTGCCCCCTGGGTTCCCTTCCATCGACATGGGGCCTCAGCTGAAGGTGGTGGAGAAGGCACGCACAGCCACCATGCTATGTGC CGCAGGCGGAAATCCAGACCCTGAGATTTCTTGGTTCAAGGACTTCCTTCCTGTAGACCCTGCCACGAGCAACGGCCGCATCAAGCAGCT GCGTTCAGGTGCCTTGCAGATAGAGAGCAGTGAGGAATCCGACCAAGGCAAGTACGAGTGTGTGGCGACCAACTCGGCAGGCACACGTTA CTCAGCCCCTGCGAACCTGTATGTGCGAGTGCGCCGCGTGGCTCCTCGTTTCTCCATCCCTCCCAGCAGCCAGGAGGTGATGCCAGGCGG CAGCGTGAACCTGACATGCGTGGCAGTGGGTGCACCCATGCCCTACGTGAAGTGGATGATGGGGGCCGAGGAGCTCACCAAGGAGGATGA GATGCCAGTTGGCCGCAACGTCCTGGAGCTCAGCAATGTCGTACGCTCTGCCAACTACACCTGTGTGGCCATCTCCTCGCTGGGCATGAT CGAGGCCACAGCCCAGGTCACAGTGAAAGGGCGAATCAAAGCCATCCAGCTGGAGTACTCAGAGGCCCGGAGAACGATGACCAACGCCCT TCGCAAGGCCCCTCAGCACACAGCTGTCGGCTTCAAACAGACGGTGCACAAGCTTCTCATCGTGGTGGAGCTGTTGCTGGGGGAGATCCC TGACCGGCTGCAGTTCCGCCAGCCCTCCCTCAAGCGCTCACTCATGCCCTATTTCCTTCTGACTCAAGCTGTCAGGACAGGAAACCTAGC CAAGTTCAACCAGGTCCTGGATCAGTTTGGGGAGAAGTTTCAAGCAGATGGGACCTACACCCTAATTATCCGGCTGCGGCACAACGTGAT TAAGACAGGTGTACGCATGATCAGCCTCTCCTATTCCCGAATCTCCTTGGCTGACATCGCCCAGAAGCTGCAGTTGGATAGCCCCGAAGA TGCAGAGTTCATTGTTGCCAAGGCCATCCGGGATGGTGTCATTGAGGCCAGCATCAACCACGAGAAGGGCTATGTCCAATCCAAGGAGAT GATTGACATCTATTCCACCCGAGAGCCCCAGCTAGCCTTCCACCAGCGCATCTCCTTCTGCCTAGATATCCACAACATGTCTGTCAAGGC CATGAGGTTTCCTCCCAAATCGTACAACAAGGACTTGGAGTCTGCAGAGGAACGGCGTGAGCGAGAACAGCAGGACTTGGAGTTTGCCAA GGAGATGGCAGAAGATGATGATGACAGCTTCCCTTGAGCTGGGGGGCTGGGGAGGGGTAGGGGGAATGGGGACAGGCTCTTTCCCCCTTG GGGGTCCCCTGCCCAGGGCACTGTCCCCATTTTCCCACACACAGCTCATATGCTGCATTCGTGCAGGGGGTGGGGGTGCTGGGAGCCAGC CACCCTGACCTCCCCCAGGGCTCCTCCCCAGCCGGTGACTTACTGTACAGCAGGCAGGAGGGTGGGCAGGCAACCTCCCCGGGCAGGGTC CTGGCCAGCAGTGTGGGAGCAGGAGGGGAAGGATAGTTCTGTGTACTCCTTTAGGGAGTGGGGGACTAGAACTGGGATGTCTTGGCTTGT >In-frame_ENST00000359947_ENST00000264639_TCGA-FP-A8CX_PTPRF_chr1_44054671_+_PSMD3_chr17_38146346_length(amino acids)=568AA_start in transcript=310_stop in transcript=2016 MWLAVELEPWMAPEPAPGRTMVPLVPALVMLGLVAGAHGDSKPVFIKVPEDQTGLSGGVASFVCQATGEPKPRITWMKKGKKVSSQRFEV IEFDDGAGSVLRIQPLRVQRDEAIYECTATNSLGEINTSAKLSVLEEEQLPPGFPSIDMGPQLKVVEKARTATMLCAAGGNPDPEISWFK DFLPVDPATSNGRIKQLRSGALQIESSEESDQGKYECVATNSAGTRYSAPANLYVRVRRVAPRFSIPPSSQEVMPGGSVNLTCVAVGAPM PYVKWMMGAEELTKEDEMPVGRNVLELSNVVRSANYTCVAISSLGMIEATAQVTVKGRIKAIQLEYSEARRTMTNALRKAPQHTAVGFKQ TVHKLLIVVELLLGEIPDRLQFRQPSLKRSLMPYFLLTQAVRTGNLAKFNQVLDQFGEKFQADGTYTLIIRLRHNVIKTGVRMISLSYSR ISLADIAQKLQLDSPEDAEFIVAKAIRDGVIEASINHEKGYVQSKEMIDIYSTREPQLAFHQRISFCLDIHNMSVKAMRFPPKSYNKDLE -------------------------------------------------------------- >In-frame_ENST00000359947_ENST00000541736_TCGA-FP-A8CX_PTPRF_chr1_44054671_+_PSMD3_chr17_38146346_length(transcript)=2140nt_BP=1289nt CGGGAGCGGCGGGAGCGGTGGCGGCGGCAGAGGCGGCGGCTCCAGCTTCGGCTCCGGCTCGGGCTCGGGCTCCGGCTCCGGCTCCGGCTC CGGCTCCAGCTCGGGTGGCGGTGGCGGGAGCGGGACCAGGTGGAGGCGGCGGCGGCAGAGGAGTGGGAGCAGCGGCCCTAGCGGCTTGCG GGGGGACATGCGGACCGACGGCCCCTGGATAGGCGGAAGGAGTGGAGGCCCTGGTGCCCGGCCCTTGGTGCTGAGTATCCAGCAAGAGTG ACCGGGGTGAAGAAGCAAAGACTCGGTTGATTGTCCTGGGCTGTGGCTGGCTGTGGAGCTAGAGCCCTGGATGGCCCCTGAGCCAGCCCC AGGGAGGACGATGGTGCCCCTTGTGCCTGCACTGGTGATGCTTGGTTTGGTGGCAGGCGCCCATGGTGACAGCAAACCTGTCTTCATTAA AGTCCCTGAGGACCAGACTGGGCTGTCAGGAGGGGTAGCCTCCTTCGTGTGCCAAGCTACAGGAGAACCCAAGCCGCGCATCACATGGAT GAAGAAGGGGAAGAAAGTCAGCTCCCAGCGCTTCGAGGTCATTGAGTTTGATGATGGGGCAGGGTCAGTGCTTCGGATCCAGCCATTGCG GGTGCAGCGAGATGAAGCCATCTATGAGTGTACAGCTACTAACAGCCTGGGTGAGATCAACACTAGTGCCAAGCTCTCAGTGCTCGAAGA GGAACAGCTGCCCCCTGGGTTCCCTTCCATCGACATGGGGCCTCAGCTGAAGGTGGTGGAGAAGGCACGCACAGCCACCATGCTATGTGC CGCAGGCGGAAATCCAGACCCTGAGATTTCTTGGTTCAAGGACTTCCTTCCTGTAGACCCTGCCACGAGCAACGGCCGCATCAAGCAGCT GCGTTCAGGTGCCTTGCAGATAGAGAGCAGTGAGGAATCCGACCAAGGCAAGTACGAGTGTGTGGCGACCAACTCGGCAGGCACACGTTA CTCAGCCCCTGCGAACCTGTATGTGCGAGTGCGCCGCGTGGCTCCTCGTTTCTCCATCCCTCCCAGCAGCCAGGAGGTGATGCCAGGCGG CAGCGTGAACCTGACATGCGTGGCAGTGGGTGCACCCATGCCCTACGTGAAGTGGATGATGGGGGCCGAGGAGCTCACCAAGGAGGATGA GATGCCAGTTGGCCGCAACGTCCTGGAGCTCAGCAATGTCGTACGCTCTGCCAACTACACCTGTGTGGCCATCTCCTCGCTGGGCATGAT CGAGGCCACAGCCCAGGTCACAGTGAAAGGGCGAATCAAAGCCATCCAGCTGGAGTACTCAGAGGCCCGGAGAACGATGACCAACGCCCT TCGCAAGGCCCCTCAGCACACAGCTGTCGGCTTCAAACAGACGGTGCACAAGCTTCTCATCGTGGTGGAGCTGTTGCTGGGGGAGATCCC TGACCGGCTGCAGTTCCGCCAGCCCTCCCTCAAGCGCTCACTCATGCCCTATTTCCTTCTGACTCAAGCTGTCAGGACAGGAAACCTAGC CAAGTTCAACCAGGTCCTGGATCAGTTTGGGGAGAAGTTTCAAGCAGATGGGACCTACACCCTAATTATCCGGCTGCGGCACAACGTGAT TAAGACAGGTGTACGCATGATCAGCCTCTCCTATTCCCGAATCTCCTTGGCTGACATCGCCCAGAAGCTGCAGTTGGATAGCCCCGAAGA TGCAGAGTTCATTGTTGCCAAGGCCATCCGGGATGGTGTCATTGAGGCCAGCATCAACCACGAGAAGGGCTATGTCCAATCCAAGGAGAT GATTGACATCTATTCCACCCGAGAGCCCCAGCTAGCCTTCCACCAGCGCATCTCCTTCTGCCTAGATATCCACAACATGTCTGTCAAGGG TTGGTAAGATTAAAAGAAGTCCCTGTATTGAGGCACTTAGCGAAGTCTAAATTGTAAAAAAGATGGCGCTGGTATCTAGCTCCACAAAAG GGCCATGAGGTTTCCTCCCAAATCGTACAACAAGGACTTGGAGTCTGCAGAGGAACGGCGTGAGCGAGAACAGCAGGACTTGGAGTTTGC >In-frame_ENST00000359947_ENST00000541736_TCGA-FP-A8CX_PTPRF_chr1_44054671_+_PSMD3_chr17_38146346_length(amino acids)=528AA_start in transcript=310_stop in transcript=1896 MWLAVELEPWMAPEPAPGRTMVPLVPALVMLGLVAGAHGDSKPVFIKVPEDQTGLSGGVASFVCQATGEPKPRITWMKKGKKVSSQRFEV IEFDDGAGSVLRIQPLRVQRDEAIYECTATNSLGEINTSAKLSVLEEEQLPPGFPSIDMGPQLKVVEKARTATMLCAAGGNPDPEISWFK DFLPVDPATSNGRIKQLRSGALQIESSEESDQGKYECVATNSAGTRYSAPANLYVRVRRVAPRFSIPPSSQEVMPGGSVNLTCVAVGAPM PYVKWMMGAEELTKEDEMPVGRNVLELSNVVRSANYTCVAISSLGMIEATAQVTVKGRIKAIQLEYSEARRTMTNALRKAPQHTAVGFKQ TVHKLLIVVELLLGEIPDRLQFRQPSLKRSLMPYFLLTQAVRTGNLAKFNQVLDQFGEKFQADGTYTLIIRLRHNVIKTGVRMISLSYSR -------------------------------------------------------------- >In-frame_ENST00000438120_ENST00000264639_TCGA-FP-A8CX_PTPRF_chr1_44054671_+_PSMD3_chr17_38146346_length(transcript)=2382nt_BP=1275nt GCGGTGGCGGCGGCAGAGGCGGCGGCTCCAGCTTCGGCTCCGGCTCGGGCTCGGGCTCCGGCTCCGGCTCCGGCTCCGGCTCCAGCTCGG GTGGCGGTGGCGGGAGCGGGACCAGGTGGAGGCGGCGGCGGCAGAGGAGTGGGAGCAGCGGCCCTAGCGGCTTGCGGGGGGACATGCGGA CCGACGGCCCCTGGATAGGCGGAAGGAGTGGAGGCCCTGGTGCCCGGCCCTTGGTGCTGAGTATCCAGCAAGAGTGACCGGGGTGAAGAA GCAAAGACTCGGTTGATTGTCCTGGGCTGTGGCTGGCTGTGGAGCTAGAGCCCTGGATGGCCCCTGAGCCAGCCCCAGGGAGGACGATGG TGCCCCTTGTGCCTGCACTGGTGATGCTTGGTTTGGTGGCAGGCGCCCATGGTGACAGCAAACCTGTCTTCATTAAAGTCCCTGAGGACC AGACTGGGCTGTCAGGAGGGGTAGCCTCCTTCGTGTGCCAAGCTACAGGAGAACCCAAGCCGCGCATCACATGGATGAAGAAGGGGAAGA AAGTCAGCTCCCAGCGCTTCGAGGTCATTGAGTTTGATGATGGGGCAGGGTCAGTGCTTCGGATCCAGCCATTGCGGGTGCAGCGAGATG AAGCCATCTATGAGTGTACAGCTACTAACAGCCTGGGTGAGATCAACACTAGTGCCAAGCTCTCAGTGCTCGAAGAGGAACAGCTGCCCC CTGGGTTCCCTTCCATCGACATGGGGCCTCAGCTGAAGGTGGTGGAGAAGGCACGCACAGCCACCATGCTATGTGCCGCAGGCGGAAATC CAGACCCTGAGATTTCTTGGTTCAAGGACTTCCTTCCTGTAGACCCTGCCACGAGCAACGGCCGCATCAAGCAGCTGCGTTCAGGTGCCT TGCAGATAGAGAGCAGTGAGGAATCCGACCAAGGCAAGTACGAGTGTGTGGCGACCAACTCGGCAGGCACACGTTACTCAGCCCCTGCGA ACCTGTATGTGCGAGTGCGCCGCGTGGCTCCTCGTTTCTCCATCCCTCCCAGCAGCCAGGAGGTGATGCCAGGCGGCAGCGTGAACCTGA CATGCGTGGCAGTGGGTGCACCCATGCCCTACGTGAAGTGGATGATGGGGGCCGAGGAGCTCACCAAGGAGGATGAGATGCCAGTTGGCC GCAACGTCCTGGAGCTCAGCAATGTCGTACGCTCTGCCAACTACACCTGTGTGGCCATCTCCTCGCTGGGCATGATCGAGGCCACAGCCC AGGTCACAGTGAAAGGGCGAATCAAAGCCATCCAGCTGGAGTACTCAGAGGCCCGGAGAACGATGACCAACGCCCTTCGCAAGGCCCCTC AGCACACAGCTGTCGGCTTCAAACAGACGGTGCACAAGCTTCTCATCGTGGTGGAGCTGTTGCTGGGGGAGATCCCTGACCGGCTGCAGT TCCGCCAGCCCTCCCTCAAGCGCTCACTCATGCCCTATTTCCTTCTGACTCAAGCTGTCAGGACAGGAAACCTAGCCAAGTTCAACCAGG TCCTGGATCAGTTTGGGGAGAAGTTTCAAGCAGATGGGACCTACACCCTAATTATCCGGCTGCGGCACAACGTGATTAAGACAGGTGTAC GCATGATCAGCCTCTCCTATTCCCGAATCTCCTTGGCTGACATCGCCCAGAAGCTGCAGTTGGATAGCCCCGAAGATGCAGAGTTCATTG TTGCCAAGGCCATCCGGGATGGTGTCATTGAGGCCAGCATCAACCACGAGAAGGGCTATGTCCAATCCAAGGAGATGATTGACATCTATT CCACCCGAGAGCCCCAGCTAGCCTTCCACCAGCGCATCTCCTTCTGCCTAGATATCCACAACATGTCTGTCAAGGCCATGAGGTTTCCTC CCAAATCGTACAACAAGGACTTGGAGTCTGCAGAGGAACGGCGTGAGCGAGAACAGCAGGACTTGGAGTTTGCCAAGGAGATGGCAGAAG ATGATGATGACAGCTTCCCTTGAGCTGGGGGGCTGGGGAGGGGTAGGGGGAATGGGGACAGGCTCTTTCCCCCTTGGGGGTCCCCTGCCC AGGGCACTGTCCCCATTTTCCCACACACAGCTCATATGCTGCATTCGTGCAGGGGGTGGGGGTGCTGGGAGCCAGCCACCCTGACCTCCC CCAGGGCTCCTCCCCAGCCGGTGACTTACTGTACAGCAGGCAGGAGGGTGGGCAGGCAACCTCCCCGGGCAGGGTCCTGGCCAGCAGTGT GGGAGCAGGAGGGGAAGGATAGTTCTGTGTACTCCTTTAGGGAGTGGGGGACTAGAACTGGGATGTCTTGGCTTGTATGTTTTTTGAAGC >In-frame_ENST00000438120_ENST00000264639_TCGA-FP-A8CX_PTPRF_chr1_44054671_+_PSMD3_chr17_38146346_length(amino acids)=568AA_start in transcript=296_stop in transcript=2002 MWLAVELEPWMAPEPAPGRTMVPLVPALVMLGLVAGAHGDSKPVFIKVPEDQTGLSGGVASFVCQATGEPKPRITWMKKGKKVSSQRFEV IEFDDGAGSVLRIQPLRVQRDEAIYECTATNSLGEINTSAKLSVLEEEQLPPGFPSIDMGPQLKVVEKARTATMLCAAGGNPDPEISWFK DFLPVDPATSNGRIKQLRSGALQIESSEESDQGKYECVATNSAGTRYSAPANLYVRVRRVAPRFSIPPSSQEVMPGGSVNLTCVAVGAPM PYVKWMMGAEELTKEDEMPVGRNVLELSNVVRSANYTCVAISSLGMIEATAQVTVKGRIKAIQLEYSEARRTMTNALRKAPQHTAVGFKQ TVHKLLIVVELLLGEIPDRLQFRQPSLKRSLMPYFLLTQAVRTGNLAKFNQVLDQFGEKFQADGTYTLIIRLRHNVIKTGVRMISLSYSR ISLADIAQKLQLDSPEDAEFIVAKAIRDGVIEASINHEKGYVQSKEMIDIYSTREPQLAFHQRISFCLDIHNMSVKAMRFPPKSYNKDLE -------------------------------------------------------------- >In-frame_ENST00000438120_ENST00000541736_TCGA-FP-A8CX_PTPRF_chr1_44054671_+_PSMD3_chr17_38146346_length(transcript)=2126nt_BP=1275nt GCGGTGGCGGCGGCAGAGGCGGCGGCTCCAGCTTCGGCTCCGGCTCGGGCTCGGGCTCCGGCTCCGGCTCCGGCTCCGGCTCCAGCTCGG GTGGCGGTGGCGGGAGCGGGACCAGGTGGAGGCGGCGGCGGCAGAGGAGTGGGAGCAGCGGCCCTAGCGGCTTGCGGGGGGACATGCGGA CCGACGGCCCCTGGATAGGCGGAAGGAGTGGAGGCCCTGGTGCCCGGCCCTTGGTGCTGAGTATCCAGCAAGAGTGACCGGGGTGAAGAA GCAAAGACTCGGTTGATTGTCCTGGGCTGTGGCTGGCTGTGGAGCTAGAGCCCTGGATGGCCCCTGAGCCAGCCCCAGGGAGGACGATGG TGCCCCTTGTGCCTGCACTGGTGATGCTTGGTTTGGTGGCAGGCGCCCATGGTGACAGCAAACCTGTCTTCATTAAAGTCCCTGAGGACC AGACTGGGCTGTCAGGAGGGGTAGCCTCCTTCGTGTGCCAAGCTACAGGAGAACCCAAGCCGCGCATCACATGGATGAAGAAGGGGAAGA AAGTCAGCTCCCAGCGCTTCGAGGTCATTGAGTTTGATGATGGGGCAGGGTCAGTGCTTCGGATCCAGCCATTGCGGGTGCAGCGAGATG AAGCCATCTATGAGTGTACAGCTACTAACAGCCTGGGTGAGATCAACACTAGTGCCAAGCTCTCAGTGCTCGAAGAGGAACAGCTGCCCC CTGGGTTCCCTTCCATCGACATGGGGCCTCAGCTGAAGGTGGTGGAGAAGGCACGCACAGCCACCATGCTATGTGCCGCAGGCGGAAATC CAGACCCTGAGATTTCTTGGTTCAAGGACTTCCTTCCTGTAGACCCTGCCACGAGCAACGGCCGCATCAAGCAGCTGCGTTCAGGTGCCT TGCAGATAGAGAGCAGTGAGGAATCCGACCAAGGCAAGTACGAGTGTGTGGCGACCAACTCGGCAGGCACACGTTACTCAGCCCCTGCGA ACCTGTATGTGCGAGTGCGCCGCGTGGCTCCTCGTTTCTCCATCCCTCCCAGCAGCCAGGAGGTGATGCCAGGCGGCAGCGTGAACCTGA CATGCGTGGCAGTGGGTGCACCCATGCCCTACGTGAAGTGGATGATGGGGGCCGAGGAGCTCACCAAGGAGGATGAGATGCCAGTTGGCC GCAACGTCCTGGAGCTCAGCAATGTCGTACGCTCTGCCAACTACACCTGTGTGGCCATCTCCTCGCTGGGCATGATCGAGGCCACAGCCC AGGTCACAGTGAAAGGGCGAATCAAAGCCATCCAGCTGGAGTACTCAGAGGCCCGGAGAACGATGACCAACGCCCTTCGCAAGGCCCCTC AGCACACAGCTGTCGGCTTCAAACAGACGGTGCACAAGCTTCTCATCGTGGTGGAGCTGTTGCTGGGGGAGATCCCTGACCGGCTGCAGT TCCGCCAGCCCTCCCTCAAGCGCTCACTCATGCCCTATTTCCTTCTGACTCAAGCTGTCAGGACAGGAAACCTAGCCAAGTTCAACCAGG TCCTGGATCAGTTTGGGGAGAAGTTTCAAGCAGATGGGACCTACACCCTAATTATCCGGCTGCGGCACAACGTGATTAAGACAGGTGTAC GCATGATCAGCCTCTCCTATTCCCGAATCTCCTTGGCTGACATCGCCCAGAAGCTGCAGTTGGATAGCCCCGAAGATGCAGAGTTCATTG TTGCCAAGGCCATCCGGGATGGTGTCATTGAGGCCAGCATCAACCACGAGAAGGGCTATGTCCAATCCAAGGAGATGATTGACATCTATT CCACCCGAGAGCCCCAGCTAGCCTTCCACCAGCGCATCTCCTTCTGCCTAGATATCCACAACATGTCTGTCAAGGGTTGGTAAGATTAAA AGAAGTCCCTGTATTGAGGCACTTAGCGAAGTCTAAATTGTAAAAAAGATGGCGCTGGTATCTAGCTCCACAAAAGGGCCATGAGGTTTC CTCCCAAATCGTACAACAAGGACTTGGAGTCTGCAGAGGAACGGCGTGAGCGAGAACAGCAGGACTTGGAGTTTGCCAAGGAGATGGCAG >In-frame_ENST00000438120_ENST00000541736_TCGA-FP-A8CX_PTPRF_chr1_44054671_+_PSMD3_chr17_38146346_length(amino acids)=528AA_start in transcript=296_stop in transcript=1882 MWLAVELEPWMAPEPAPGRTMVPLVPALVMLGLVAGAHGDSKPVFIKVPEDQTGLSGGVASFVCQATGEPKPRITWMKKGKKVSSQRFEV IEFDDGAGSVLRIQPLRVQRDEAIYECTATNSLGEINTSAKLSVLEEEQLPPGFPSIDMGPQLKVVEKARTATMLCAAGGNPDPEISWFK DFLPVDPATSNGRIKQLRSGALQIESSEESDQGKYECVATNSAGTRYSAPANLYVRVRRVAPRFSIPPSSQEVMPGGSVNLTCVAVGAPM PYVKWMMGAEELTKEDEMPVGRNVLELSNVVRSANYTCVAISSLGMIEATAQVTVKGRIKAIQLEYSEARRTMTNALRKAPQHTAVGFKQ TVHKLLIVVELLLGEIPDRLQFRQPSLKRSLMPYFLLTQAVRTGNLAKFNQVLDQFGEKFQADGTYTLIIRLRHNVIKTGVRMISLSYSR -------------------------------------------------------------- >In-frame_ENST00000372413_ENST00000264639_TCGA-FP-A8CX_PTPRF_chr1_44054671_+_PSMD3_chr17_38146346_length(transcript)=2102nt_BP=995nt GGTTGATTGTCCTGGGCTGTGGCTGGCTGTGGAGCTAGAGCCCTGGATGGCCCCTGAGCCAGCCCCAGGGAGGACGATGGTGCCCCTTGT GCCTGCACTGGTGATGCTTGGTTTGGTGGCAGGCGCCCATGGTGACAGCAAACCTGTCTTCATTAAAGTCCCTGAGGACCAGACTGGGCT GTCAGGAGGGGTAGCCTCCTTCGTGTGCCAAGCTACAGGAGAACCCAAGCCGCGCATCACATGGATGAAGAAGGGGAAGAAAGTCAGCTC CCAGCGCTTCGAGGTCATTGAGTTTGATGATGGGGCAGGGTCAGTGCTTCGGATCCAGCCATTGCGGGTGCAGCGAGATGAAGCCATCTA TGAGTGTACAGCTACTAACAGCCTGGGTGAGATCAACACTAGTGCCAAGCTCTCAGTGCTCGAAGAGGAACAGCTGCCCCCTGGGTTCCC TTCCATCGACATGGGGCCTCAGCTGAAGGTGGTGGAGAAGGCACGCACAGCCACCATGCTATGTGCCGCAGGCGGAAATCCAGACCCTGA GATTTCTTGGTTCAAGGACTTCCTTCCTGTAGACCCTGCCACGAGCAACGGCCGCATCAAGCAGCTGCGTTCAGGTGCCTTGCAGATAGA GAGCAGTGAGGAATCCGACCAAGGCAAGTACGAGTGTGTGGCGACCAACTCGGCAGGCACACGTTACTCAGCCCCTGCGAACCTGTATGT GCGAGTGCGCCGCGTGGCTCCTCGTTTCTCCATCCCTCCCAGCAGCCAGGAGGTGATGCCAGGCGGCAGCGTGAACCTGACATGCGTGGC AGTGGGTGCACCCATGCCCTACGTGAAGTGGATGATGGGGGCCGAGGAGCTCACCAAGGAGGATGAGATGCCAGTTGGCCGCAACGTCCT GGAGCTCAGCAATGTCGTACGCTCTGCCAACTACACCTGTGTGGCCATCTCCTCGCTGGGCATGATCGAGGCCACAGCCCAGGTCACAGT GAAAGGGCGAATCAAAGCCATCCAGCTGGAGTACTCAGAGGCCCGGAGAACGATGACCAACGCCCTTCGCAAGGCCCCTCAGCACACAGC TGTCGGCTTCAAACAGACGGTGCACAAGCTTCTCATCGTGGTGGAGCTGTTGCTGGGGGAGATCCCTGACCGGCTGCAGTTCCGCCAGCC CTCCCTCAAGCGCTCACTCATGCCCTATTTCCTTCTGACTCAAGCTGTCAGGACAGGAAACCTAGCCAAGTTCAACCAGGTCCTGGATCA GTTTGGGGAGAAGTTTCAAGCAGATGGGACCTACACCCTAATTATCCGGCTGCGGCACAACGTGATTAAGACAGGTGTACGCATGATCAG CCTCTCCTATTCCCGAATCTCCTTGGCTGACATCGCCCAGAAGCTGCAGTTGGATAGCCCCGAAGATGCAGAGTTCATTGTTGCCAAGGC CATCCGGGATGGTGTCATTGAGGCCAGCATCAACCACGAGAAGGGCTATGTCCAATCCAAGGAGATGATTGACATCTATTCCACCCGAGA GCCCCAGCTAGCCTTCCACCAGCGCATCTCCTTCTGCCTAGATATCCACAACATGTCTGTCAAGGCCATGAGGTTTCCTCCCAAATCGTA CAACAAGGACTTGGAGTCTGCAGAGGAACGGCGTGAGCGAGAACAGCAGGACTTGGAGTTTGCCAAGGAGATGGCAGAAGATGATGATGA CAGCTTCCCTTGAGCTGGGGGGCTGGGGAGGGGTAGGGGGAATGGGGACAGGCTCTTTCCCCCTTGGGGGTCCCCTGCCCAGGGCACTGT CCCCATTTTCCCACACACAGCTCATATGCTGCATTCGTGCAGGGGGTGGGGGTGCTGGGAGCCAGCCACCCTGACCTCCCCCAGGGCTCC TCCCCAGCCGGTGACTTACTGTACAGCAGGCAGGAGGGTGGGCAGGCAACCTCCCCGGGCAGGGTCCTGGCCAGCAGTGTGGGAGCAGGA GGGGAAGGATAGTTCTGTGTACTCCTTTAGGGAGTGGGGGACTAGAACTGGGATGTCTTGGCTTGTATGTTTTTTGAAGCTTCGATTATG >In-frame_ENST00000372413_ENST00000264639_TCGA-FP-A8CX_PTPRF_chr1_44054671_+_PSMD3_chr17_38146346_length(amino acids)=568AA_start in transcript=16_stop in transcript=1722 MWLAVELEPWMAPEPAPGRTMVPLVPALVMLGLVAGAHGDSKPVFIKVPEDQTGLSGGVASFVCQATGEPKPRITWMKKGKKVSSQRFEV IEFDDGAGSVLRIQPLRVQRDEAIYECTATNSLGEINTSAKLSVLEEEQLPPGFPSIDMGPQLKVVEKARTATMLCAAGGNPDPEISWFK DFLPVDPATSNGRIKQLRSGALQIESSEESDQGKYECVATNSAGTRYSAPANLYVRVRRVAPRFSIPPSSQEVMPGGSVNLTCVAVGAPM PYVKWMMGAEELTKEDEMPVGRNVLELSNVVRSANYTCVAISSLGMIEATAQVTVKGRIKAIQLEYSEARRTMTNALRKAPQHTAVGFKQ TVHKLLIVVELLLGEIPDRLQFRQPSLKRSLMPYFLLTQAVRTGNLAKFNQVLDQFGEKFQADGTYTLIIRLRHNVIKTGVRMISLSYSR ISLADIAQKLQLDSPEDAEFIVAKAIRDGVIEASINHEKGYVQSKEMIDIYSTREPQLAFHQRISFCLDIHNMSVKAMRFPPKSYNKDLE -------------------------------------------------------------- >In-frame_ENST00000372413_ENST00000541736_TCGA-FP-A8CX_PTPRF_chr1_44054671_+_PSMD3_chr17_38146346_length(transcript)=1846nt_BP=995nt GGTTGATTGTCCTGGGCTGTGGCTGGCTGTGGAGCTAGAGCCCTGGATGGCCCCTGAGCCAGCCCCAGGGAGGACGATGGTGCCCCTTGT GCCTGCACTGGTGATGCTTGGTTTGGTGGCAGGCGCCCATGGTGACAGCAAACCTGTCTTCATTAAAGTCCCTGAGGACCAGACTGGGCT GTCAGGAGGGGTAGCCTCCTTCGTGTGCCAAGCTACAGGAGAACCCAAGCCGCGCATCACATGGATGAAGAAGGGGAAGAAAGTCAGCTC CCAGCGCTTCGAGGTCATTGAGTTTGATGATGGGGCAGGGTCAGTGCTTCGGATCCAGCCATTGCGGGTGCAGCGAGATGAAGCCATCTA TGAGTGTACAGCTACTAACAGCCTGGGTGAGATCAACACTAGTGCCAAGCTCTCAGTGCTCGAAGAGGAACAGCTGCCCCCTGGGTTCCC TTCCATCGACATGGGGCCTCAGCTGAAGGTGGTGGAGAAGGCACGCACAGCCACCATGCTATGTGCCGCAGGCGGAAATCCAGACCCTGA GATTTCTTGGTTCAAGGACTTCCTTCCTGTAGACCCTGCCACGAGCAACGGCCGCATCAAGCAGCTGCGTTCAGGTGCCTTGCAGATAGA GAGCAGTGAGGAATCCGACCAAGGCAAGTACGAGTGTGTGGCGACCAACTCGGCAGGCACACGTTACTCAGCCCCTGCGAACCTGTATGT GCGAGTGCGCCGCGTGGCTCCTCGTTTCTCCATCCCTCCCAGCAGCCAGGAGGTGATGCCAGGCGGCAGCGTGAACCTGACATGCGTGGC AGTGGGTGCACCCATGCCCTACGTGAAGTGGATGATGGGGGCCGAGGAGCTCACCAAGGAGGATGAGATGCCAGTTGGCCGCAACGTCCT GGAGCTCAGCAATGTCGTACGCTCTGCCAACTACACCTGTGTGGCCATCTCCTCGCTGGGCATGATCGAGGCCACAGCCCAGGTCACAGT GAAAGGGCGAATCAAAGCCATCCAGCTGGAGTACTCAGAGGCCCGGAGAACGATGACCAACGCCCTTCGCAAGGCCCCTCAGCACACAGC TGTCGGCTTCAAACAGACGGTGCACAAGCTTCTCATCGTGGTGGAGCTGTTGCTGGGGGAGATCCCTGACCGGCTGCAGTTCCGCCAGCC CTCCCTCAAGCGCTCACTCATGCCCTATTTCCTTCTGACTCAAGCTGTCAGGACAGGAAACCTAGCCAAGTTCAACCAGGTCCTGGATCA GTTTGGGGAGAAGTTTCAAGCAGATGGGACCTACACCCTAATTATCCGGCTGCGGCACAACGTGATTAAGACAGGTGTACGCATGATCAG CCTCTCCTATTCCCGAATCTCCTTGGCTGACATCGCCCAGAAGCTGCAGTTGGATAGCCCCGAAGATGCAGAGTTCATTGTTGCCAAGGC CATCCGGGATGGTGTCATTGAGGCCAGCATCAACCACGAGAAGGGCTATGTCCAATCCAAGGAGATGATTGACATCTATTCCACCCGAGA GCCCCAGCTAGCCTTCCACCAGCGCATCTCCTTCTGCCTAGATATCCACAACATGTCTGTCAAGGGTTGGTAAGATTAAAAGAAGTCCCT GTATTGAGGCACTTAGCGAAGTCTAAATTGTAAAAAAGATGGCGCTGGTATCTAGCTCCACAAAAGGGCCATGAGGTTTCCTCCCAAATC GTACAACAAGGACTTGGAGTCTGCAGAGGAACGGCGTGAGCGAGAACAGCAGGACTTGGAGTTTGCCAAGGAGATGGCAGAAGATGATGA >In-frame_ENST00000372413_ENST00000541736_TCGA-FP-A8CX_PTPRF_chr1_44054671_+_PSMD3_chr17_38146346_length(amino acids)=528AA_start in transcript=16_stop in transcript=1602 MWLAVELEPWMAPEPAPGRTMVPLVPALVMLGLVAGAHGDSKPVFIKVPEDQTGLSGGVASFVCQATGEPKPRITWMKKGKKVSSQRFEV IEFDDGAGSVLRIQPLRVQRDEAIYECTATNSLGEINTSAKLSVLEEEQLPPGFPSIDMGPQLKVVEKARTATMLCAAGGNPDPEISWFK DFLPVDPATSNGRIKQLRSGALQIESSEESDQGKYECVATNSAGTRYSAPANLYVRVRRVAPRFSIPPSSQEVMPGGSVNLTCVAVGAPM PYVKWMMGAEELTKEDEMPVGRNVLELSNVVRSANYTCVAISSLGMIEATAQVTVKGRIKAIQLEYSEARRTMTNALRKAPQHTAVGFKQ TVHKLLIVVELLLGEIPDRLQFRQPSLKRSLMPYFLLTQAVRTGNLAKFNQVLDQFGEKFQADGTYTLIIRLRHNVIKTGVRMISLSYSR -------------------------------------------------------------- >In-frame_ENST00000372414_ENST00000264639_TCGA-FP-A8CX_PTPRF_chr1_44054671_+_PSMD3_chr17_38146346_length(transcript)=2102nt_BP=995nt GGTTGATTGTCCTGGGCTGTGGCTGGCTGTGGAGCTAGAGCCCTGGATGGCCCCTGAGCCAGCCCCAGGGAGGACGATGGTGCCCCTTGT GCCTGCACTGGTGATGCTTGGTTTGGTGGCAGGCGCCCATGGTGACAGCAAACCTGTCTTCATTAAAGTCCCTGAGGACCAGACTGGGCT GTCAGGAGGGGTAGCCTCCTTCGTGTGCCAAGCTACAGGAGAACCCAAGCCGCGCATCACATGGATGAAGAAGGGGAAGAAAGTCAGCTC CCAGCGCTTCGAGGTCATTGAGTTTGATGATGGGGCAGGGTCAGTGCTTCGGATCCAGCCATTGCGGGTGCAGCGAGATGAAGCCATCTA TGAGTGTACAGCTACTAACAGCCTGGGTGAGATCAACACTAGTGCCAAGCTCTCAGTGCTCGAAGAGGAACAGCTGCCCCCTGGGTTCCC TTCCATCGACATGGGGCCTCAGCTGAAGGTGGTGGAGAAGGCACGCACAGCCACCATGCTATGTGCCGCAGGCGGAAATCCAGACCCTGA GATTTCTTGGTTCAAGGACTTCCTTCCTGTAGACCCTGCCACGAGCAACGGCCGCATCAAGCAGCTGCGTTCAGGTGCCTTGCAGATAGA GAGCAGTGAGGAATCCGACCAAGGCAAGTACGAGTGTGTGGCGACCAACTCGGCAGGCACACGTTACTCAGCCCCTGCGAACCTGTATGT GCGAGTGCGCCGCGTGGCTCCTCGTTTCTCCATCCCTCCCAGCAGCCAGGAGGTGATGCCAGGCGGCAGCGTGAACCTGACATGCGTGGC AGTGGGTGCACCCATGCCCTACGTGAAGTGGATGATGGGGGCCGAGGAGCTCACCAAGGAGGATGAGATGCCAGTTGGCCGCAACGTCCT GGAGCTCAGCAATGTCGTACGCTCTGCCAACTACACCTGTGTGGCCATCTCCTCGCTGGGCATGATCGAGGCCACAGCCCAGGTCACAGT GAAAGGGCGAATCAAAGCCATCCAGCTGGAGTACTCAGAGGCCCGGAGAACGATGACCAACGCCCTTCGCAAGGCCCCTCAGCACACAGC TGTCGGCTTCAAACAGACGGTGCACAAGCTTCTCATCGTGGTGGAGCTGTTGCTGGGGGAGATCCCTGACCGGCTGCAGTTCCGCCAGCC CTCCCTCAAGCGCTCACTCATGCCCTATTTCCTTCTGACTCAAGCTGTCAGGACAGGAAACCTAGCCAAGTTCAACCAGGTCCTGGATCA GTTTGGGGAGAAGTTTCAAGCAGATGGGACCTACACCCTAATTATCCGGCTGCGGCACAACGTGATTAAGACAGGTGTACGCATGATCAG CCTCTCCTATTCCCGAATCTCCTTGGCTGACATCGCCCAGAAGCTGCAGTTGGATAGCCCCGAAGATGCAGAGTTCATTGTTGCCAAGGC CATCCGGGATGGTGTCATTGAGGCCAGCATCAACCACGAGAAGGGCTATGTCCAATCCAAGGAGATGATTGACATCTATTCCACCCGAGA GCCCCAGCTAGCCTTCCACCAGCGCATCTCCTTCTGCCTAGATATCCACAACATGTCTGTCAAGGCCATGAGGTTTCCTCCCAAATCGTA CAACAAGGACTTGGAGTCTGCAGAGGAACGGCGTGAGCGAGAACAGCAGGACTTGGAGTTTGCCAAGGAGATGGCAGAAGATGATGATGA CAGCTTCCCTTGAGCTGGGGGGCTGGGGAGGGGTAGGGGGAATGGGGACAGGCTCTTTCCCCCTTGGGGGTCCCCTGCCCAGGGCACTGT CCCCATTTTCCCACACACAGCTCATATGCTGCATTCGTGCAGGGGGTGGGGGTGCTGGGAGCCAGCCACCCTGACCTCCCCCAGGGCTCC TCCCCAGCCGGTGACTTACTGTACAGCAGGCAGGAGGGTGGGCAGGCAACCTCCCCGGGCAGGGTCCTGGCCAGCAGTGTGGGAGCAGGA GGGGAAGGATAGTTCTGTGTACTCCTTTAGGGAGTGGGGGACTAGAACTGGGATGTCTTGGCTTGTATGTTTTTTGAAGCTTCGATTATG >In-frame_ENST00000372414_ENST00000264639_TCGA-FP-A8CX_PTPRF_chr1_44054671_+_PSMD3_chr17_38146346_length(amino acids)=568AA_start in transcript=16_stop in transcript=1722 MWLAVELEPWMAPEPAPGRTMVPLVPALVMLGLVAGAHGDSKPVFIKVPEDQTGLSGGVASFVCQATGEPKPRITWMKKGKKVSSQRFEV IEFDDGAGSVLRIQPLRVQRDEAIYECTATNSLGEINTSAKLSVLEEEQLPPGFPSIDMGPQLKVVEKARTATMLCAAGGNPDPEISWFK DFLPVDPATSNGRIKQLRSGALQIESSEESDQGKYECVATNSAGTRYSAPANLYVRVRRVAPRFSIPPSSQEVMPGGSVNLTCVAVGAPM PYVKWMMGAEELTKEDEMPVGRNVLELSNVVRSANYTCVAISSLGMIEATAQVTVKGRIKAIQLEYSEARRTMTNALRKAPQHTAVGFKQ TVHKLLIVVELLLGEIPDRLQFRQPSLKRSLMPYFLLTQAVRTGNLAKFNQVLDQFGEKFQADGTYTLIIRLRHNVIKTGVRMISLSYSR ISLADIAQKLQLDSPEDAEFIVAKAIRDGVIEASINHEKGYVQSKEMIDIYSTREPQLAFHQRISFCLDIHNMSVKAMRFPPKSYNKDLE -------------------------------------------------------------- >In-frame_ENST00000372414_ENST00000541736_TCGA-FP-A8CX_PTPRF_chr1_44054671_+_PSMD3_chr17_38146346_length(transcript)=1846nt_BP=995nt GGTTGATTGTCCTGGGCTGTGGCTGGCTGTGGAGCTAGAGCCCTGGATGGCCCCTGAGCCAGCCCCAGGGAGGACGATGGTGCCCCTTGT GCCTGCACTGGTGATGCTTGGTTTGGTGGCAGGCGCCCATGGTGACAGCAAACCTGTCTTCATTAAAGTCCCTGAGGACCAGACTGGGCT GTCAGGAGGGGTAGCCTCCTTCGTGTGCCAAGCTACAGGAGAACCCAAGCCGCGCATCACATGGATGAAGAAGGGGAAGAAAGTCAGCTC CCAGCGCTTCGAGGTCATTGAGTTTGATGATGGGGCAGGGTCAGTGCTTCGGATCCAGCCATTGCGGGTGCAGCGAGATGAAGCCATCTA TGAGTGTACAGCTACTAACAGCCTGGGTGAGATCAACACTAGTGCCAAGCTCTCAGTGCTCGAAGAGGAACAGCTGCCCCCTGGGTTCCC TTCCATCGACATGGGGCCTCAGCTGAAGGTGGTGGAGAAGGCACGCACAGCCACCATGCTATGTGCCGCAGGCGGAAATCCAGACCCTGA GATTTCTTGGTTCAAGGACTTCCTTCCTGTAGACCCTGCCACGAGCAACGGCCGCATCAAGCAGCTGCGTTCAGGTGCCTTGCAGATAGA GAGCAGTGAGGAATCCGACCAAGGCAAGTACGAGTGTGTGGCGACCAACTCGGCAGGCACACGTTACTCAGCCCCTGCGAACCTGTATGT GCGAGTGCGCCGCGTGGCTCCTCGTTTCTCCATCCCTCCCAGCAGCCAGGAGGTGATGCCAGGCGGCAGCGTGAACCTGACATGCGTGGC AGTGGGTGCACCCATGCCCTACGTGAAGTGGATGATGGGGGCCGAGGAGCTCACCAAGGAGGATGAGATGCCAGTTGGCCGCAACGTCCT GGAGCTCAGCAATGTCGTACGCTCTGCCAACTACACCTGTGTGGCCATCTCCTCGCTGGGCATGATCGAGGCCACAGCCCAGGTCACAGT GAAAGGGCGAATCAAAGCCATCCAGCTGGAGTACTCAGAGGCCCGGAGAACGATGACCAACGCCCTTCGCAAGGCCCCTCAGCACACAGC TGTCGGCTTCAAACAGACGGTGCACAAGCTTCTCATCGTGGTGGAGCTGTTGCTGGGGGAGATCCCTGACCGGCTGCAGTTCCGCCAGCC CTCCCTCAAGCGCTCACTCATGCCCTATTTCCTTCTGACTCAAGCTGTCAGGACAGGAAACCTAGCCAAGTTCAACCAGGTCCTGGATCA GTTTGGGGAGAAGTTTCAAGCAGATGGGACCTACACCCTAATTATCCGGCTGCGGCACAACGTGATTAAGACAGGTGTACGCATGATCAG CCTCTCCTATTCCCGAATCTCCTTGGCTGACATCGCCCAGAAGCTGCAGTTGGATAGCCCCGAAGATGCAGAGTTCATTGTTGCCAAGGC CATCCGGGATGGTGTCATTGAGGCCAGCATCAACCACGAGAAGGGCTATGTCCAATCCAAGGAGATGATTGACATCTATTCCACCCGAGA GCCCCAGCTAGCCTTCCACCAGCGCATCTCCTTCTGCCTAGATATCCACAACATGTCTGTCAAGGGTTGGTAAGATTAAAAGAAGTCCCT GTATTGAGGCACTTAGCGAAGTCTAAATTGTAAAAAAGATGGCGCTGGTATCTAGCTCCACAAAAGGGCCATGAGGTTTCCTCCCAAATC GTACAACAAGGACTTGGAGTCTGCAGAGGAACGGCGTGAGCGAGAACAGCAGGACTTGGAGTTTGCCAAGGAGATGGCAGAAGATGATGA >In-frame_ENST00000372414_ENST00000541736_TCGA-FP-A8CX_PTPRF_chr1_44054671_+_PSMD3_chr17_38146346_length(amino acids)=528AA_start in transcript=16_stop in transcript=1602 MWLAVELEPWMAPEPAPGRTMVPLVPALVMLGLVAGAHGDSKPVFIKVPEDQTGLSGGVASFVCQATGEPKPRITWMKKGKKVSSQRFEV IEFDDGAGSVLRIQPLRVQRDEAIYECTATNSLGEINTSAKLSVLEEEQLPPGFPSIDMGPQLKVVEKARTATMLCAAGGNPDPEISWFK DFLPVDPATSNGRIKQLRSGALQIESSEESDQGKYECVATNSAGTRYSAPANLYVRVRRVAPRFSIPPSSQEVMPGGSVNLTCVAVGAPM PYVKWMMGAEELTKEDEMPVGRNVLELSNVVRSANYTCVAISSLGMIEATAQVTVKGRIKAIQLEYSEARRTMTNALRKAPQHTAVGFKQ TVHKLLIVVELLLGEIPDRLQFRQPSLKRSLMPYFLLTQAVRTGNLAKFNQVLDQFGEKFQADGTYTLIIRLRHNVIKTGVRMISLSYSR -------------------------------------------------------------- |
Top |
Fusion Gene PPI Analysis for PTPRF-PSMD3 |
Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in |
Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
- Retained PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
- Lost PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
- Retained PPIs, but lost function due to frame-shift fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs for PTPRF-PSMD3 |
Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.8 2021-05-08) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
Related Diseases for PTPRF-PSMD3 |
Diseases associated with fusion partners. (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Hgene | PTPRF | C0024623 | Malignant neoplasm of stomach | 1 | CTD_human |
Hgene | PTPRF | C0038356 | Stomach Neoplasms | 1 | CTD_human |
Hgene | PTPRF | C0175755 | Congenital absent nipple | 1 | GENOMICS_ENGLAND |
Hgene | PTPRF | C0235874 | Disease Exacerbation | 1 | CTD_human |
Hgene | PTPRF | C0345967 | Malignant mesothelioma | 1 | CTD_human |
Hgene | PTPRF | C0432357 | Congenital absence of breast with absent nipple | 1 | ORPHANET |
Hgene | PTPRF | C1708349 | Hereditary Diffuse Gastric Cancer | 1 | CTD_human |
Tgene | PSMD3 | C0019693 | HIV Infections | 1 | CTD_human |
Tgene | PSMD3 | C4505456 | HIV Coinfection | 1 | CTD_human |